Loading data
CHRNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 148.84 m USD | 147.2 m USD | 152.33 m USD | 157.08 m USD | 153.01 m USD |
| Cost of revenue | 43.21 m USD | 39.39 m USD | 39.55 m USD | 40.58 m USD | 34.94 m USD |
| Research and development expense | 5.17 m USD | 3.43 m USD | 1.64 m USD | 1.33 m USD | 920 k USD |
| Operating profit | 26.29 m USD | 25.59 m USD | 29.29 m USD | 26.73 m USD | 36.29 m USD |
| Interest expense | — | — | — | 93 k USD | 513 k USD |
| Profit before tax | 25.69 m USD | 25.93 m USD | 30.59 m USD | 26.85 m USD | 36.33 m USD |
| Income tax expense | 73 k USD | -34 k USD | 61 k USD | 413 k USD | 976 k USD |
| Net income (reported basis) | 25.62 m USD | 25.97 m USD | 30.48 m USD | 26.89 m USD | 35.29 m USD |
| Basic earnings per share | 24.07 USD/share | 125.72 USD/share | 150.31 USD/share | 3.95 USD/share | 5.4 USD/share |
| Diluted earnings per share | 24.07 USD/share | 125.72 USD/share | 150.31 USD/share | 3.95 USD/share | 5.4 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.